monoisoamyl-2,3-dimercaptosuccinate and Nerve Degeneration

monoisoamyl-2,3-dimercaptosuccinate has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flora, SJ; Mehta, A; Mishra, D; Pachauri, V; Saxena, G	1

Other Studies

1 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and Nerve Degeneration

Article	Year
Combinational chelation therapy abrogates lead-induced neurodegeneration in rats. Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2 Topics: Animals; Antioxidants; Apoptosis; Behavior, Animal; Biogenic Amines; Calcium; Captopril; Chelating Agents; Cytochromes c; Disease Models, Animal; DNA Damage; Drug Therapy, Combination; Exploratory Behavior; Lead Poisoning, Nervous System; Learning; Male; Membrane Potential, Mitochondrial; Memory; Mitochondria; Motor Activity; Nerve Degeneration; Neurons; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer	2009

Article

Year

Combinational chelation therapy abrogates lead-induced neurodegeneration in rats.

Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

Topics: Animals; Antioxidants; Apoptosis; Behavior, Animal; Biogenic Amines; Calcium; Captopril; Chelating Agents; Cytochromes c; Disease Models, Animal; DNA Damage; Drug Therapy, Combination; Exploratory Behavior; Lead Poisoning, Nervous System; Learning; Male; Membrane Potential, Mitochondrial; Memory; Mitochondria; Motor Activity; Nerve Degeneration; Neurons; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer

2009